• Oncologist joins Parker Institute for Cancer Immunotherapy as senior VP

    7 monthes ago - By Healio

    Ute Dugan, MD, PhD, has been appointed senior vice president for clinical research at Parker Institute for Cancer Immunotherapy.
    She will oversee the institute's clinical development, regulatory affairs and translational medicine efforts, with an emphasis on advancing novel breakthrough treatment combinations and overcoming immunotherapy resistance.
    “Dr. Dugan has been an incredible collaborator and champion of [Parker Institute for Cancer Immunotherapy's] mission over the last several years, and we're excited to welcome her to our team,” Sean Parker, the institute's
    Read more ...